These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20809902)

  • 21. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M; Ulbricht K; Schmidt RE; Witte T
    Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optic neuropathy and acute transverse myelopathy in primary Sjögren's syndrome.
    Harada T; Ohashi T; Miyagishi R; Fukuda H; Yoshida K; Tagawa Y; Matsuda H
    Jpn J Ophthalmol; 1995; 39(2):162-5. PubMed ID: 8538072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central nervous system disease in Sjögren's syndrome.
    Escudero D; Latorre P; Codina M; Coll-Cantí J; Coll J
    Ann Med Interne (Paris); 1995; 146(4):239-42. PubMed ID: 7653943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective studies on the progress of sicca symptoms in Sjögren's syndrome: subclinical disease develops into the clinical syndrome.
    Ichikawa Y; Takaya M; Uchiyama M; Shimizu H; Tokunaga M; Saitoh H; Arimori S
    Tokai J Exp Clin Med; 1988 Jun; 13(2):85-90. PubMed ID: 3250005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients.
    Fauchais AL; Ouattara B; Gondran G; Lalloué F; Petit D; Ly K; Lambert M; Launay D; Loustaud-Ratti V; Bezanahari H; Liozon E; Hachulla E; Jauberteau MO; Vidal E; Hatron PY
    Rheumatology (Oxford); 2010 Jun; 49(6):1164-72. PubMed ID: 20299380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry.
    Mekinian A; Ravaud P; Larroche C; Hachulla E; Gombert B; Blanchard-Delaunay C; Cantagrel A; Fain O; Sibilia J; Gottenberg JE; Mariette X;
    Clin Exp Rheumatol; 2012; 30(2):208-12. PubMed ID: 22341206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome.
    Barry RJ; Sutcliffe N; Isenberg DA; Price E; Goldblatt F; Adler M; Canavan A; Hamburger J; Richards A; Regan M; Gadsby K; Rigby S; Jones A; Mathew R; Mulherin D; Stevenson A; Nightingale P; Rauz S; Bowman SJ
    Rheumatology (Oxford); 2008 Aug; 47(8):1193-8. PubMed ID: 18524804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system disease in primary Sjögren's syndrome.
    De Backer H; Dehaene I
    Acta Neurol Belg; 1995; 95(3):142-6. PubMed ID: 7484051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.
    Annunziata P; Giorgio A; De Santi L; Zipoli V; Portaccio E; Amato MP; Clerici R; Scarpini E; Moscato G; Iudice A; Vacca G; Orefice G; Morra VB; Maimone D
    J Neurol Sci; 2006 May; 244(1-2):97-102. PubMed ID: 16473370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjögren's syndrome.
    Lee M; Rutka JA; Slomovic AR; McComb J; Bailey DJ; Bookman AA
    J Rheumatol; 1998 Feb; 25(2):247-53. PubMed ID: 9489815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
    Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
    J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible cortical lesions in primary Sjögren's syndrome presenting with meningoencephalitis as an initial manifestation.
    Hirohata M; Yasukawa Y; Ishida C; Komai K; Yamada M
    J Neurol Sci; 2005 May; 232(1-2):111-3. PubMed ID: 15850591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
    de Seze J; Delalande S; Fauchais AL; Hachulla E; Stojkovic T; Ferriby D; Hatron PY; Vermersch P
    J Rheumatol; 2006 Apr; 33(4):709-11. PubMed ID: 16583474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatigue in primary Sjögren's syndrome--a link to sickness behaviour in animals?
    Harboe E; Tjensvoll AB; Vefring HK; Gøransson LG; Kvaløy JT; Omdal R
    Brain Behav Immun; 2009 Nov; 23(8):1104-8. PubMed ID: 19560535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of Sjögren's syndrome with subacute transverse myelitis as the initial manifestation].
    Arai C; Furutani R; Ushiyama M
    Rinsho Shinkeigaku; 2002 Jul; 42(7):613-8. PubMed ID: 12661106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sjögren's syndrome (SS) in patients with human T cell leukemia virus I associated myelopathy: paradoxical features of the major salivary glands compared to classical SS.
    Izumi M; Nakamura H; Nakamura T; Eguchi K; Nakamura T
    J Rheumatol; 1999 Dec; 26(12):2609-14. PubMed ID: 10606370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.